Literature DB >> 31228187

The many faces of myocardial ischaemia and angina.

Bernard I Levy1, Gerd Heusch2, Paolo G Camici3.   

Abstract

Obstructive disease of the epicardial coronary arteries is the main cause of angina. However, a number of patients with anginal symptoms have normal coronaries or non-obstructive coronary artery disease (CAD) despite electrocardiographic evidence of ischaemia during stress testing. In addition to limited microvascular vasodilator capacity, the coronary microcirculation of these patients is particularly sensitive to vasoconstrictor stimuli, in a condition known as microvascular angina. This review briefly summarizes the determinants and control of coronary blood flow (CBF) and myocardial perfusion. It subsequently analyses the mechanisms responsible for transient myocardial ischaemia: obstructive CAD, coronary spasm and coronary microvascular dysfunction in the absence of epicardial coronary lesions, and variable combinations of structural anomalies, impaired endothelium-dependent and/or -independent vasodilation, and enhanced perception of pain. Lastly, we exemplify mechanism of angina during tachycardia. Distal to a coronary stenosis, coronary dilator reserve is already recruited and can be nearly exhausted at rest distal to a severe stenosis. Increased heart rate reduces the duration of diastole and thus CBF when metabolic vasodilation is no longer able to increase CBF. The increase in myocardial oxygen consumption and resulting metabolic vasodilation in adjacent myocardium without stenotic coronary arteries further acts to divert blood flow away from the post-stenotic coronary vascular bed through collaterals. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Basic science research; Coronary circulation; Myocardial ischaemia; Pathophysiology

Mesh:

Year:  2019        PMID: 31228187     DOI: 10.1093/cvr/cvz160

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

Review 1.  Recent updates on novel therapeutic targets of cardiovascular diseases.

Authors:  Muhammad Afzal
Journal:  Mol Cell Biochem       Date:  2020-08-26       Impact factor: 3.396

Review 2.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

3.  Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease.

Authors:  Jens van de Wouw; Oana Sorop; Ruben W A van Drie; Richard W B van Duin; Isabel T N Nguyen; Jaap A Joles; Marianne C Verhaar; Daphne Merkus; Dirk J Duncker
Journal:  Basic Res Cardiol       Date:  2020-02-25       Impact factor: 17.165

Review 4.  Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities.

Authors:  Ilona Cuijpers; Steven J Simmonds; Marc van Bilsen; Elżbieta Czarnowska; Arantxa González Miqueo; Stephane Heymans; Annika R Kuhn; Paul Mulder; Anna Ratajska; Elizabeth A V Jones; Ebba Brakenhielm
Journal:  Basic Res Cardiol       Date:  2020-05-25       Impact factor: 17.165

5.  COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.

Authors:  Tomasz J Guzik; Saidi A Mohiddin; Anthony Dimarco; Vimal Patel; Kostas Savvatis; Federica M Marelli-Berg; Meena S Madhur; Maciej Tomaszewski; Pasquale Maffia; Fulvio D'Acquisto; Stuart A Nicklin; Ali J Marian; Ryszard Nosalski; Eleanor C Murray; Bartlomiej Guzik; Colin Berry; Rhian M Touyz; Reinhold Kreutz; Dao Wen Wang; David Bhella; Orlando Sagliocco; Filippo Crea; Emma C Thomson; Iain B McInnes
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

Review 6.  Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?

Authors:  Jiongshan Zhang; Wei Liu; Mingmin Bi; Jinwen Xu; Hongzhi Yang; Yaxing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-16

Review 7.  Myocardial oedema: pathophysiological basis and implications for the failing heart.

Authors:  Francisco Vasques-Nóvoa; António Angélico-Gonçalves; José M G Alvarenga; João Nobrega; Rui J Cerqueira; Jennifer Mancio; Adelino F Leite-Moreira; Roberto Roncon-Albuquerque
Journal:  ESC Heart Fail       Date:  2022-02-11

Review 8.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

9.  ISCHEMIA: new questions from a landmark trial.

Authors:  Andrew Morrow; Novalia Sidik; Colin Berry
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

Review 10.  What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?

Authors:  Colin Berry; Andrew J Morrow; Mario Marzilli; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-12       Impact factor: 3.947

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.